Dr. Reddy’s Launches NIVORZ®, First Homegrown Nivolumab Biosimilar Approved for 12 Oncology Indications in India
Immune checkpoint inhibitors changed cancer treatment more than almost any other drug class in the last decade, turning previously untreatable…